Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 4, 1996, Pages 254-256

  Kozu, Tomoko ^a   Sueoka, Eisaburo ^a   Okabe, Sachiko ^a   Sueoka, Naoko ^a   Komori, Atsumasa ^a   Fujiki, Hirota ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Acute myeloid leukemia; Gene therapy; Ribozyme

Indexed keywords

RIBOZYME;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CHIMERA; CONTROLLED STUDY; DNA RNA HYBRIDIZATION; GENE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA; DNA-BINDING PROTEINS; GROWTH INHIBITORS; HUMANS; LEUKEMIA, MYELOID; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; RNA, CATALYTIC; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029867415     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01209655     Document Type: Article

References (13)

1. Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55: 599-629
2. Haseloff J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585-591
3. Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N, Ohki M (1993) Junctions of the AML1/MTG8(ETO) fusion are constant in t(8:21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 82: 1270-1276
4. Matozaki S, Nakagawa T, Kawaguchi R, Aozaki R, Tsutsumi M, Murayama T, Koizumi T, Nishimura R, Isobe T, Chihara K (1995) Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. Br J Haematol 89: 805-811
5. Matsushita H, Kobayashi H, Mori S, Kizaki M, Ikeda Y (1995) Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21). Biochem Biophys Res Commun 215: 431-437
6. Mitelman F, Kaneko Y, Berger R (1994) Report of the committee on chromosome changes in neoplasia. In: Cuticchia AJ, Pearson PL (eds) Human gene mapping: a compendium. Johns Hopkins University Press, Baltimore, pp 773-812
7. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M (1991) t(8;21) Breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88: 10431-10434
8. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M (1993) The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 12: 2715-2721
9. Pace U, Bookman JM, Mackay BJ, Wilson H, Miller J, Dimitrovsky E, Goldberg AR (1994) A ribozyme which discriminates in vitro between PML/RARα, the t(15;17)-associated fusion RNA of acute promyelocytic leukemia, and PML and RARα, the transcripts from the nonrearranged alleles. Cancer Res 54: 6365-6369
10. Rossi JJ (1995) Therapeutic antisense and ribozymes. Br Med Bull 51: 217-225
11. Snyder DS, Wu Y, Wang JL, Rossi JJ, Swiderski P, Kaplan BE, Forman SJ (1993) Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood 82: 600-605
12. Taylor NR, Kaplan BE, Swiderski P, Li H, Rossi JJ (1992) Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo. Nucleic Acids Res 20: 4559-4565
13. Yang J-h, Perreault J-P, Labuda D, Usman N, Cedergren R (1990) Mixed DNA/RNA polymers are cleaved by the hammerhead ribozyme. Biochemistry 29: 11156-11160